Some important neuropeptides, such as orexin (hypocretin) and apelin, have been shown to modulate Aβ levels and pathology of AD (Roh et al., 2014; Masoumi et al., 2018), which indicates that manipulation of neuropeptides may be able to treat AD. Here, HCRT is linked to Alzheimer disease.